Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies
Fig 5
Forest plot of RR benefit of alloHSCT in intermediate-risk AML-CR1.